Literature DB >> 11901830

Pharmacogenetics: the Rx perspective.

G Renegar1, P Rieser, P Manasco.   

Abstract

Pharmacogenetics is changing the way medicines are discovered, developed and delivered to patients. In this article, we present the 'prescription' perspective--how the results of pharmacogenetic research will help minimize the risk of costly adverse drug reactions and treatment failures, by providing predictive tools to enable healthcare providers to prescribe the right medicine for the right patient. We discuss the challenges of this research and its clinical application; its implications for drug development; evolving concepts of informed consent; related ethical, legal and social issues; changing definitions of 'genetic testing'; and the creation of an international Pharmacogenetics Working Group.

Entities:  

Mesh:

Year:  2001        PMID: 11901830     DOI: 10.1586/14737159.1.3.255

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  1 in total

1.  Broad consent versus dynamic consent in biobank research: is passive participation an ethical problem?

Authors:  Kristin Solum Steinsbekk; Bjørn Kåre Myskja; Berge Solberg
Journal:  Eur J Hum Genet       Date:  2013-01-09       Impact factor: 4.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.